KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Prepaid Assets (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Prepaid Assets for 18 consecutive years, with $620.9 million as the latest value for Q1 2026.

  • For Q1 2026, Prepaid Assets rose 32.42% year-over-year to $620.9 million; the TTM value through Mar 2026 reached $620.9 million, up 32.42%, while the annual FY2025 figure was $474.8 million, 35.97% up from the prior year.
  • Prepaid Assets hit $620.9 million in Q1 2026 for Regeneron Pharmaceuticals, up from $474.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $681.9 million in Q2 2024 and bottomed at $349.2 million in Q4 2024.
  • Average Prepaid Assets over 5 years is $481.9 million, with a median of $446.4 million recorded in 2022.
  • Year-over-year, Prepaid Assets skyrocketed 98.92% in 2022 and then crashed 37.23% in 2023.
  • Regeneron Pharmaceuticals' Prepaid Assets stood at $411.2 million in 2022, then fell by 5.98% to $386.6 million in 2023, then dropped by 9.67% to $349.2 million in 2024, then soared by 35.97% to $474.8 million in 2025, then surged by 30.77% to $620.9 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $620.9 million, $474.8 million, and $595.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.